We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Healthcare 11.34%
3 Financials 9.38%
4 Consumer Discretionary 8.31%
5 Communication Services 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPST icon
7326
Tempest Therapeutics
TPST
$18.9M
$1K ﹤0.01%
43
UPXI icon
7327
Upexi
UPXI
$58.9M
$1K ﹤0.01%
7
USEA icon
7328
United Maritime
USEA
$25.4M
$1K ﹤0.01%
+943
New +$2.09K
UTSI icon
7329
UTStarcom
UTSI
$23.2M
$1K ﹤0.01%
250
VFMO icon
7330
Vanguard US Momentum Factor ETF
VFMO
$1.91B
$1K ﹤0.01%
5
VFVA icon
7331
Vanguard US Value Factor ETF
VFVA
$935M
$1K ﹤0.01%
8
VIGL
7332
DELISTED
Vigil Neuroscience
VIGL
$1K ﹤0.01%
130
-3,208
-96% -$23.5K
VVOS icon
7333
Vivos Therapeutics
VVOS
$4.37M
$1K ﹤0.01%
56
-40
-42% -$1.22K
WILC icon
7334
G. Willi-Food International
WILC
$377M
$1K ﹤0.01%
+70
New +$1.11K
XPL icon
7335
Solitario Resources
XPL
$74.8M
$1K ﹤0.01%
2,253
-187,130
-99% -$102K
YCBD icon
7336
cbdMD
YCBD
$6.14M
$1K ﹤0.01%
10
-3
-23% -$431
LFWD icon
7337
ReWalk Robotics
LFWD
$21.3M
$1K ﹤0.01%
+16
New +$1.32K
IVF
7338
INVO Fertility Inc
IVF
$1.84M
0
PEV
7339
DELISTED
Phoenix Motor Inc. Common Stock
PEV
$1K ﹤0.01%
+740
New +$2.07K
CYTH
7340
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$1K ﹤0.01%
443
CRKN
7341
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
JWSM.WS
7342
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$1K ﹤0.01%
12,462
BBSA
7343
DELISTED
JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF
BBSA
$1K ﹤0.01%
11
-456
-98% -$21.8K
AUGX
7344
DELISTED
Augmedix, Inc. Common Stock
AUGX
$1K ﹤0.01%
1,000
SDPI
7345
DELISTED
Superior Drilling Products Inc.
SDPI
$1K ﹤0.01%
2,002
+2
+0.1% +$2
AFTY
7346
DELISTED
Pacer CSOP FTSE China A50 ETF
AFTY
$1K ﹤0.01%
50
SCTL
7347
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1K ﹤0.01%
867
-3,338
-79% -$3.88K
ROSS.U
7348
DELISTED
Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ROSS.U
$1K ﹤0.01%
100
ESHY
7349
DELISTED
Xtrackers J.P. Morgan ESG USD High Yield Corporate Bond ETF
ESHY
$1K ﹤0.01%
54
-16
-23% -$292
VRPX
7350
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$1K ﹤0.01%
4
-68
-94% -$24.5K

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.